TAO Synergies (TAOX) Shares Outstanding (Entity) (2019 - 2026)
Powered by 
Analysis
TAO Synergies (TAOX) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | 722.67 Mn |
| 10 | TAO Synergies | 30.41 Mn | 30.41 Mn | - | 7.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.47 Mn |
| Mar 31, 2026 | 7.47 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 7.37 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Dec 31, 2022 | 7.27 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 6.81 Mn |
| Dec 31, 2021 | 5.02 Mn |
| Sep 30, 2021 | 6.14 Mn |